Key pharmacovigilance stakeholders' experiences of direct patient reporting of adverse drug reactions and their prospects of future development in the European Union

P. Inacio, A. Cavaco, E. Allan, M. Airaksinen

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalPublic Health
Volume155
Pages (from-to)119-128
Number of pages10
ISSN0033-3506
DOIs
Publication statusPublished - Feb 2018
MoE publication typeA1 Journal article-refereed

Fields of Science

  • Pharmacovigilance
  • Spontaneous reporting
  • Patient-reported adverse drug reactions
  • Risk management
  • European Union
  • QUALITATIVE RESEARCH
  • RISK-MANAGEMENT
  • MEDICINES
  • INFORMATION
  • INVOLVEMENT
  • SYSTEM
  • HEALTH
  • SAFETY
  • 3142 Public health care science, environmental and occupational health

Cite this

@article{f9b41fbd7588446fa6175dd180805ba9,
title = "Key pharmacovigilance stakeholders' experiences of direct patient reporting of adverse drug reactions and their prospects of future development in the European Union",
keywords = "Pharmacovigilance, Spontaneous reporting, Patient-reported adverse drug reactions, Risk management, European Union, QUALITATIVE RESEARCH, RISK-MANAGEMENT, MEDICINES, INFORMATION, INVOLVEMENT, SYSTEM, HEALTH, SAFETY, 3142 Public health care science, environmental and occupational health",
author = "P. Inacio and A. Cavaco and E. Allan and M. Airaksinen",
year = "2018",
month = "2",
doi = "10.1016/j.puhe.2017.11.023",
language = "English",
volume = "155",
pages = "119--128",
journal = "Public Health",
issn = "0033-3506",
publisher = "W.B. Saunders",

}

Key pharmacovigilance stakeholders' experiences of direct patient reporting of adverse drug reactions and their prospects of future development in the European Union. / Inacio, P.; Cavaco, A.; Allan, E.; Airaksinen, M.

In: Public Health, Vol. 155, 02.2018, p. 119-128.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - Key pharmacovigilance stakeholders' experiences of direct patient reporting of adverse drug reactions and their prospects of future development in the European Union

AU - Inacio, P.

AU - Cavaco, A.

AU - Allan, E.

AU - Airaksinen, M.

PY - 2018/2

Y1 - 2018/2

KW - Pharmacovigilance

KW - Spontaneous reporting

KW - Patient-reported adverse drug reactions

KW - Risk management

KW - European Union

KW - QUALITATIVE RESEARCH

KW - RISK-MANAGEMENT

KW - MEDICINES

KW - INFORMATION

KW - INVOLVEMENT

KW - SYSTEM

KW - HEALTH

KW - SAFETY

KW - 3142 Public health care science, environmental and occupational health

U2 - 10.1016/j.puhe.2017.11.023

DO - 10.1016/j.puhe.2017.11.023

M3 - Article

VL - 155

SP - 119

EP - 128

JO - Public Health

JF - Public Health

SN - 0033-3506

ER -